Journal Home
Search for

Alert me when new articles in Press are available via Request Articles in Press Alert via email or via Request RSS feed of Articles in Press

Lung Cancer
Articles in Press
Viewing 1-60 of 143 Next 60 Articles > Page:  [1]  2  3
display abstract citation download email a colleague
Display:
1. 

Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer
In Press Corrected Proof , Available online 16 November 2009
Kazutoshi Komiya, Naoko Sueoka-Aragane, Akemi Sato, Takashi Hisatomi, Toru Sakuragi, Masahiro Mitsuoka, Toshimi Sato, Shinichiro Hayashi, Hiroto Izumi, Makoto Tsuneoka, Eisaburo Sueoka
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.010
Abstract | Full Text | Full-Text PDF (1198 KB) | Add-Ons


2. 

Targeted therapies for non-small cell lung cancer REVIEW
In Press Corrected Proof , Available online 16 November 2009
Wolfram C.M. Dempke, Tamas Suto, Martin Reck
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.012
Abstract | Full Text | Full-Text PDF (1052 KB)


3. 

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer
In Press Corrected Proof , Available online 13 November 2009
Hai-bo Sun, Si-yu Wang, Wei Ou, Bin-bin Zhang, Hua Yang, Qin Fang
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.002
Abstract | Full Text | Full-Text PDF (142 KB)


4. 

Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinoma
In Press Corrected Proof , Available online 13 November 2009
Wang Rui, Zhang You-Wei, Chen Long-Bang
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.009
Abstract | Full Text | Full-Text PDF (716 KB)


5. 

Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT)
In Press Corrected Proof , Available online 12 November 2009
Marco Trovo, Anna Linda, Issam El Naqa, Cylen Javidan-Nejad, Jeffrey Bradley
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.006
Abstract | Full Text | Full-Text PDF (786 KB)


6. 

First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale
In Press Corrected Proof , Available online 12 November 2009
Vittorio Gebbia, Vito Lorusso, Domenico Galetta, Michele Caruso M, Giuseppe Palomba, Fernando Riccardi, Nicolò Borsellino, Francesco Carrozza, Silvana Leo, Francesco Ferraù, Saverio Cinieri, Gianfranco Mancuso, Sergio Mancarella, Giuseppe Colucci
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.008
Abstract | Full Text | Full-Text PDF (443 KB)


7. 

Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event CASE REPORT
In Press Corrected Proof , Available online 09 November 2009
Shotaro Ide, Hiroshi Soda, Tomoaki Hakariya, Shinnosuke Takemoto, Hiroshi Ishimoto, Shinya Tomari, Toyomitsu Sawai, Seiji Nagashima, Masataka Furukawa, Yoichi Nakamura, Shigeru Kohno
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.007
Abstract | Full Text | Full-Text PDF (357 KB)


8. 

Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells
In Press Corrected Proof , Available online 06 November 2009
Hussein A.N. Al-Wadei, Mohammed H. Al-Wadei, Thomas Masi, Hildegard M. Schuller
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.011
Abstract | Full Text | Full-Text PDF (742 KB)


9. 

Lung cancer in the pregnant woman: To treat or not to treat, that is the question REVIEW
In Press Corrected Proof , Available online 06 November 2009
Hatem A. Azim, Fedro A. Peccatori, Nicholas Pavlidis
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.006
Abstract | Full Text | Full-Text PDF (365 KB)


10. 

Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
In Press Corrected Proof , Available online 05 November 2009
Ryo Nagashio, Yuichi Sato, Toshihide Matsumoto, Taihei Kageyama, Yukitoshi Satoh, Ryuge Shinichiro, Noriyuki Masuda, Naoki Goshima, Shi-Xu Jiang, Isao Okayasu
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.015
Abstract | Full Text | Full-Text PDF (817 KB)


11. 

Well-differentiated papillary mesothelioma with invasion to the chest wall CASE REPORT
In Press Corrected Proof , Available online 02 November 2009
Ikuko Torii, Masaki Hashimoto, Takayuki Terada, Nobuyuki Kondo, Hiroaki Fushimi, Kohki Shimazu, Shin-ichi Takeda, Teruhisa Takuwa, Yoshitomo Okumura, Ayuko Sato, Tadashi Yamamoto, Kazuya Fukuoka, Fumihiro Tanaka, Takashi Nishigami, Takashi Nakano, Seiki Hasegawa, Tohru Tsujimura
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.004
Abstract | Full Text | Full-Text PDF (1155 KB)


12. 

Down-regulation of collagen XVIII expression by thiazolidinediones through a PPARγ-dependent mechanism in human non-small lung cancer cells
In Press Corrected Proof , Available online 02 November 2009
Sachie Tanno, Takayuki Yoshizaki, Yoshihiro Tsuchiya, Shima Kumei, Satoshi Tanno, Toshikatsu Okumura
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.005
Abstract | Full Text | Full-Text PDF (584 KB)


13. 

Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
In Press Corrected Proof , Available online 30 October 2009
Jian Li, Zhen-Nan Li, Li-Chao Yu, Qian-Lei Bao, Jian-Rong Wu, Shun-Bing Shi, Xiao-Qin Li
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.013
Abstract | Full Text | Full-Text PDF (187 KB)


14. 

Methodological aspects of lung cancer clinical trials in the era of targeted agents REVIEW
In Press Corrected Proof , Available online 30 October 2009
Massimo Di Maio, Ciro Gallo, Ermelinda De Maio, Alessandro Morabito, Maria Carmela Piccirillo, Cesare Gridelli, Francesco Perrone
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.001
Abstract | Full Text | Full-Text PDF (484 KB)


15. 

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
In Press Corrected Proof , Available online 30 October 2009
Nicolas Girard, Françoise Mornex, Jean-Yves Douillard, Nadine Bossard, Elisabeth Quoix, Véronique Beckendorf, Dominique Grunenwald, Elodie Amour, Bernard Milleron
Lung Cancer
DOI: 10.1016/j.lungcan.2009.10.003
Abstract | Full Text | Full-Text PDF (577 KB)


16. 

KRAS mutation, KRASLCS6 polymorphism, and non-small cell lung cancer
In Press Corrected Proof , Available online 26 October 2009
H.H. Nelson, B.C. Christensen, S.L. Plaza, J.K. Wiencke, C.J. Marsit, K.T. Kelsey
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.008
Abstract | Full Text | Full-Text PDF (119 KB)


17. 

Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells
In Press Corrected Proof , Available online 26 October 2009
Jingyan Wei, Weili Yan, Xiuling Li, Yunfei Ding, Hsin-Hsiung Tai
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.009
Abstract | Full Text | Full-Text PDF (657 KB)


18. 

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
In Press Corrected Proof , Available online 26 October 2009
Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki, Maria Trypaki, Emmanouel Kontopodis, Efstathios Stathopoulos, Dimitris Mavroudis, Vassilis Georgoulias, Alexandra Voutsina
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.010
Abstract | Full Text | Full-Text PDF (302 KB)


19. 

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
In Press Corrected Proof , Available online 26 October 2009
Kyoichi Kaira, Noriaki Sunaga, Yoshio Tomizawa, Noriko Yanagitani, Kimihiro Shimizu, Hisao Imai, Mitsuyoshi Utsugi, Yasuki Iwasaki, Hironobu Iijima, Hiroaki Tsurumaki, Akihiro Yoshii, Naoto Fueki, Takeshi Hisada, Tamotsu Ishizuka, Ryusei Saito, Masatomo Mori
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.012
Abstract | Full Text | Full-Text PDF (277 KB)


20. 

The role of βIII tubulin in predicting chemoresistance in non-small cell lung cancer REVIEW
In Press Corrected Proof , Available online 15 October 2009
Pascal Sève, Tony Reiman, Charles Dumontet
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.007
Abstract | Full Text | Full-Text PDF (272 KB)


21. 

Limited contamination in the Dutch–Belgian randomized lung cancer screening trial (NELSON)
In Press Corrected Proof , Available online 05 October 2009
Eleonora Baecke, Harry J. de Koning, Suzie J. Otto, Carola A. van Iersel, Rob J. van Klaveren
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.015
Abstract | Full Text | Full-Text PDF (352 KB)


22. 

CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
In Press Corrected Proof , Available online 05 October 2009
Ping Zhan, Jing Wang, Yu Zhang, Li-Xin Qiu, Su-feng Zhao, Qian Qian, Shu-Zhen Wei, Li-Ke Yu, Yong Song
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.001
Abstract | Full Text | Full-Text PDF (322 KB)


23. 

Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer
In Press Corrected Proof , Available online 05 October 2009
Anne Mathieu, Birgit Weynand, Eric Verbeken, Susana Da Silva, Christine Decaestecker, Isabelle Salmon, Pieter Demetter
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.003
Abstract | Full Text | Full-Text PDF (368 KB)


24. 

Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer
In Press Corrected Proof , Available online 05 October 2009
Su-Hee Cho, Se-Il Go, Gyeong-Won Lee, Jung Hun Kang, Hoon-Gu Kim, Seok Hyun Kim, Yu Ji Cho, Yi Yeong Jeong, Ho-Cheol Kim, Jong Duk Lee, Young Sil Hwang
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.005
Abstract | Full Text | Full-Text PDF (205 KB)


25. 

Emerging profile of cetuximab in non-small cell lung cancer
In Press Corrected Proof , Available online 28 September 2009
David S. Ettinger
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.012
Abstract | Full Text | Full-Text PDF (157 KB)


26. 

Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer
In Press Corrected Proof , Available online 25 September 2009
Quan-Sing Ng, Vicky Goh, Jessica Milner, Josefin Sundin, David Wellsted, Michele I. Saunders, Peter J. Hoskin
Lung Cancer
DOI: 10.1016/j.lungcan.2009.09.002
Abstract | Full Text | Full-Text PDF (924 KB)


27. 

Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study
In Press Corrected Proof , Available online 24 September 2009
N. Xenidis, A. Kotsakis, A. Kalykaki, Ch. Christophyllakis, S. Giassas, N. Kentepozidis, A. Polyzos, L. Chelis, N. Vardakis, L. Vamvakas, V. Georgoulias, S. Kakolyris
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.012
Abstract | Full Text | Full-Text PDF (144 KB)


28. 

Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke REVIEW
In Press Corrected Proof , Available online 18 September 2009
Lynsay L. Waller, Antonius A. Miller, W. Jeffrey Petty
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.014
Abstract | Full Text | Full-Text PDF (132 KB)


29. 

Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Permetrexed and radiotherapy
In Press Corrected Proof , Available online 18 September 2009
Servet Bölükbas, Christian Manegold, Michael Eberlein, Thomas Bergmann, Annette Fisseler-Eckhoff, Joachim Schirren
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.019
Abstract | Full Text | Full-Text PDF (379 KB)


30. 

Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection
In Press Corrected Proof , Available online 17 September 2009
Mohit Agarwal, Govinda Brahmanday, Gary W. Chmielewski, Robert J. Welsh, K.P. Ravikrishnan
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.008
Abstract | Full Text | Full-Text PDF (327 KB)


31. 

EUS-FNA in the preoperative staging of non-small cell lung cancer
In Press Corrected Proof , Available online 17 September 2009
M. Talebian, M.B. von Bartheld, J. Braun, M.I.M. Versteegh, O.M. Dekkers, K.F. Rabe, J.T. Annema
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.016
Abstract | Full Text | Full-Text PDF (236 KB) | Add-Ons


32. 

Pathological confirmation of primary lung cancer following breast cancer
In Press Corrected Proof , Available online 11 September 2009
M. Tennis, B. Singh, A. Hjerpe, M. Prochazka, K. Czene, P. Hall, P.G. Shields
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.018
Abstract | Full Text | Full-Text PDF (335 KB)


33. 

Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
In Press Corrected Proof , Available online 10 September 2009
Raffit Hassan, Charles Schweizer, Kun F. Lu, Barbara Schuler, Alan T. Remaley, Susan C. Weil, Ira Pastan
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.016
Abstract | Full Text | Full-Text PDF (462 KB)


34. 

O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
In Press Corrected Proof , Available online 10 September 2009
Pei-Fang Wu, Kuan-Ting Kuo, Lu-Ting Kuo, Yi-Ting Lin, Wei-Chung Lee, Yen-Shen Lu, Chih-Hsin Yang, Ruey-Meei Wu, Yong-Kwang Tu, Jui-Chang Tasi, Ham-Min Tseng, Sheng-Hong Tseng, Ann-Lii Cheng, Ching-Hung Lin
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.010
Abstract | Full Text | Full-Text PDF (516 KB)


35. 

Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer
In Press Corrected Proof , Available online 09 September 2009
Yuichi Takiguchi, Yuji Tada, Akihiko Gemma, Shoji Kudoh, Mitsunori Hino, Kozo Yoshimori, Akinobu Yoshimura, Keiichi Nagao, Hisanobu Niitani
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.009
Abstract | Full Text | Full-Text PDF (228 KB)


36. 

Detection of disseminated tumour cells in mediastinoscopic lymph node biopsies and endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected lung cancer
In Press Corrected Proof , Available online 07 September 2009
S. Dango, B. Cucuruz, O. Mayer, S. Brabletz, M. Follo, M. Elze, W. Sienel, T. Brabletz, B. Passlick
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.003
Abstract | Full Text | Full-Text PDF (256 KB)


37. 

Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients
In Press Corrected Proof , Available online 07 September 2009
Enric Carcereny, Jose Luis Ramirez, Maria Sanchez-Ronco, Dolores Isla, Manuel Cobo, Teresa Moran, Itziar de Aguirre, Tatsuro Okamoto, Jia Wei, Mariano Provencio, Guillermo Lopez-Vivanco, Carlos Camps, Manuel Domine, Vicente Alberola, Jose Miguel Sanchez, Bartomeu Massuti, Pedro Mendez, Miquel Taron, Rafael Rosell
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.004
Abstract | Full Text | Full-Text PDF (215 KB) | Add-Ons


38. 

Didymin, a dietary flavonoid glycoside from citrus fruits, induces Fas-mediated apoptotic pathway in human non-small-cell lung cancer cells in vitro and in vivo
In Press Corrected Proof , Available online 07 September 2009
Jen-Yu Hung, Ya-Ling Hsu, Ying-Chin Ko, Ying-Ming Tsai, Chih-Jen Yang, Ming-Shyan Huang, Po-Lin Kuo
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.013
Abstract | Full Text | Full-Text PDF (1496 KB)


39. 

Variation in vascular distribution in small lung cancers
In Press Corrected Proof , Available online 01 September 2009
Lijuan Zhang, David F. Yankelevitz, Claudia I. Henschke, Anthony P. Reeves, Madeline F. Vazquez, Darryl Carter
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.006
Abstract | Full Text | Full-Text PDF (873 KB)


40. 

Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung
In Press Corrected Proof , Available online 01 September 2009
Yoshihiro Minamiya, Hajime Saito, Naoko Takahashi, Manabu Ito, Kazuhiro Imai, Takashi Ono, Satoru Motoyama, Junichi Ogawa
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.015
Abstract | Full Text | Full-Text PDF (747 KB)


41. 

Limited thymectomy for stage I or II thymomas
In Press Corrected Proof , Available online 01 September 2009
Takuya Onuki, Shigemi Ishikawa, Kesato Iguchi, Yukinobu Goto, Mitsuaki Sakai, Masaharu Inagaki, Tatsuo Yamamoto, Masataka Onizuka, Yukio Sato, Kiyoshi Ohara, Yuzuru Sakakibara
Lung Cancer
DOI: 10.1016/j.lungcan.2009.08.001
Abstract | Full Text | Full-Text PDF (265 KB)


42. 

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study
In Press Corrected Proof , Available online 27 August 2009
Hyun Ju Lee, Xianhua Xu, Gheeyoung Choe, Doo Hyun Chung, Jeong-Wook Seo, Jae Ho Lee, Choon-Taek Lee, Sanghoon Jheon, Sook-Whan Sung, Jin-Haeng Chung
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.014
Abstract | Full Text | Full-Text PDF (1522 KB)


43. 

Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancer
In Press Corrected Proof , Available online 25 August 2009
Satoshi Igawa, Reiko Watanabe, Ichiro Ito, Haruyasu Murakami, Toshiaki Takahashi, Yukiko Nakamura, Asuka Tsuya, Kyoichi Kaira, Tateaki Naito, Masahiro Endo, Nobuyuki Yamamoto, Toru Kameya
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.003
Abstract | Full Text | Full-Text PDF (2437 KB)


44. 

Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lung cancer cells
In Press Corrected Proof , Available online 25 August 2009
Jen-Yu Hung, Ya-Ling Hsu, Wen-Chiu Ni, Ying-Ming Tsai, Chih-Jen Yang, Po-Lin Kuo, Ming-Shyan Huang
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.017
Abstract | Full Text | Full-Text PDF (1414 KB)


45. 

Nanoparticle mediated delivery of 2′-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells
In Press Corrected Proof , Available online 20 August 2009
Julia Beisner, Meng Dong, Sebastian Taetz, Noha Nafee, Ernst-Ulrich Griese, Ulrich Schaefer, Claus-Michael Lehr, Ulrich Klotz, Thomas E. Mürdter
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.010
Abstract | Full Text | Full-Text PDF (2833 KB)


46. 

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
In Press Corrected Proof , Available online 20 August 2009
Giorgio V. Scagliotti, Paul Germonpré, Leon Bosquée, Johan Vansteenkiste, R. Gervais, David Planchard, Martin Reck, Filippo De Marinis, Jin Soo Lee, Keunchil Park, Bonne Biesma, Steven Gans, R. Ramlau, Aleusandra Szczesna, A. Makhson, G. Manikhas, Bruno Morgan, Y. Zhu, Kai C. Chan, Joachim von Pawel
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.011
Abstract | Full Text | Full-Text PDF (499 KB)


47. 

Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?
In Press Corrected Proof , Available online 20 August 2009
Mariano Provencio, Ramón de Las Peñas, Carlos Camps, Angel Artal, Bartomeu Massuti, Manuel Cobo, Francisco Javier Pérez, Antonio Sánchez, Rafael Rosell
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.018
Abstract | Full Text | Full-Text PDF (131 KB)


48. 

A multicenter phase II study of belotecan, new camptothecin analogue, in patients with previously untreated extensive stage disease small cell lung cancer
In Press Corrected Proof , Available online 17 August 2009
S.J. Kim, J.S. Kim, S.C. Kim, Y.K. Kim, Y.K. Kim, J.Y. Kang, H.K. Yoon, J.S. Song, S.H. Lee, H.S. Moon, J.W. Kim, K.H. Kim, C.H. Kim, B.Y. Shim, H.K. Kim
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.002
Abstract | Full Text | Full-Text PDF (168 KB)


49. 

The prognostic significance of ERCC1, BRCA1, XRCC1, and βIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection
In Press Corrected Proof , Available online 17 August 2009
Chang Hyun Kang, Bo Gun Jang, Dong-Wan Kim, Doo Hyun Chung, Young Tae Kim, Sanghoon Jheon, Sook-Whan Sung, Joo Hyun Kim
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.004
Abstract | Full Text | Full-Text PDF (506 KB)


50. 

Relationship between primary lesion FDG uptake and clinical stage at PET–CT for non-small cell lung cancer patients: An observation
In Press Corrected Proof , Available online 17 August 2009
Minghuan Li, Yun Sun, Yuhui Liu, Anqin Han, Shuqiang Zhao, Li Ma, Jinsong Zheng, Jinming Yu
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.009
Abstract | Full Text | Full-Text PDF (179 KB)


51. 

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer
In Press Corrected Proof , Available online 12 August 2009
Jong-Mu Sun, Do-Youn Oh, Se-Hoon Lee, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Jong Seok Lee, Young-Whan Kim, Dae Seog Heo, Yung-Jue Bang
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.013
Abstract | Full Text | Full-Text PDF (313 KB)


52. 

Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin α recombinant adenoviral vectors against Lewis lung carcinoma
In Press Corrected Proof , Available online 11 August 2009
Junping Xie, Liang Xiong, Xiaonan Tao, Xiao Li, Yuan Su, Xiaohua Hou, Huanzhong Shi
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.007
Abstract | Full Text | Full-Text PDF (1585 KB)


53. 

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
In Press Corrected Proof , Available online 10 August 2009
Aminah Jatoi, Howard L. Ritter, Amylou Dueck, Phuong L. Nguyen, Daniel A. Nikcevich, Ronnie F. Luyun, Bassam I. Mattar, Charles L. Loprinzi
Lung Cancer
DOI: 10.1016/j.lungcan.2009.06.020
Abstract | Full Text | Full-Text PDF (409 KB)


54. 

Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: Why pneumonectomy should be avoided
In Press Corrected Proof , Available online 07 August 2009
Ingrid Kappers, Johanna W. van Sandick, Sjaak A. Burgers, José S.A. Belderbos, Nico van Zandwijk, Houke M. Klomp
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.001
Abstract | Full Text | Full-Text PDF (332 KB)


55. 

Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
In Press Corrected Proof , Available online 07 August 2009
Mario Scartozzi, Paola Mazzanti, Riccardo Giampieri, Rossana Berardi, Eva Galizia, Stefano Gasparini, Lina Zuccatosta, Stefano Cascinu
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.008
Abstract | Full Text | Full-Text PDF (253 KB)


56. 

Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapy
In Press Corrected Proof , Available online 06 August 2009
Yoshio Tomizawa, Yuka Fujita, Atsuhisa Tamura, Masahiro Shirai, Satoshi Shibata, Tsutomu Kawabata, Takuo Shibayama, Shimao Fukai, Masaaki Kawahra, Ryusei Saito
Lung Cancer
DOI: 10.1016/j.lungcan.2009.06.025
Abstract | Full Text | Full-Text PDF (189 KB)


57. 

Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients
In Press Corrected Proof , Available online 06 August 2009
Masahiko Higashiyama, Kazuyuki Oda, Jiro Okami, Jun Maeda, Ken Kodama, Fumio Imamura, Kazuhiko Minamikawa, Toshikazu Takano, Hisayuki Kobayashi
Lung Cancer
DOI: 10.1016/j.lungcan.2009.07.005
Abstract | Full Text | Full-Text PDF (195 KB)


58. 

Angiogenic markers in breath condensate identify non-small cell lung cancer
In Press Corrected Proof , Available online 03 August 2009
C. Gessner, B. Rechner, S. Hammerschmidt, H. Kuhn, G. Hoheisel, U. Sack, P. Ruschpler, H. Wirtz
Lung Cancer
DOI: 10.1016/j.lungcan.2009.06.010
Abstract | Full Text | Full-Text PDF (539 KB)


59. 

A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
In Press Corrected Proof , Available online 03 August 2009
Hye Jin Kim, Tae Gyoon Kim, Hyun Jeong Lee, Jee Ho Kim, Byung Hoon Lim, Jae Won Seo, Eun Mi Kang, Byung Uk Lee, Young Mi Ahn, Yong Ho Roh, Seung-Hyun Nam, Bong-Seog Kim
Lung Cancer
DOI: 10.1016/j.lungcan.2009.06.026
Abstract | Full Text | Full-Text PDF (229 KB)


60. 

Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis
In Press Corrected Proof , Available online 31 July 2009
Francesca Maria Carozzi, Simonetta Bisanzi, Patrizia Falini, Cristina Sani, Giulia Venturini, Andrea Lopes Pegna, Roberto Bianchi, Cristina Ronchi, Giulia Picozzi, Mario Mascalchi, Laura Carrozzi, Filomena Baliva, Francesco Pistelli, Laura Tavanti, Fabio Falaschi, Michela Grazzini, Florio Innocenti, Eugenio Paci, for the ITALUNG Study Research group
Lung Cancer
DOI: 10.1016/j.lungcan.2009.06.015
Abstract | Full Text | Full-Text PDF (260 KB)

display abstract citation download email a colleague
Display:
Viewing 1-60 of 143 Next 60 Articles > Page:  [1]  2  3

Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.